GERM vs. PSIL

Last updated Jun 4, 2026

GERM (Amplify Treatments, Testing and Advancements ETF) and PSIL (AdvisorShares Psychedelics ETF) are both Health & Biotech Equities funds. GERM is passively managed, while PSIL is actively managed. Over the past year, GERM returned 0.00% vs 65.52% for PSIL. GERM charges 0.68%/yr vs 1.00%/yr for PSIL.

Performance

GERM vs. PSIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and AdvisorShares Psychedelics ETF (PSIL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PSIL

• 1D: -2.57%
• 1M: 1.88%
• YTD: 20.15%
• 6M: 23.74%
• 1Y: 65.52%
• 3Y*: 9.55%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. PSIL - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
PSIL AdvisorShares Psychedelics ETF	20.15%	74.55%	39.61%

GERM vs. PSIL - Sectors Allocation Comparison

Sectors	GERM	PSIL
Healthcare	99.3%	100.0%
Financial Services	0.4%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

GERM vs. PSIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSIL

PSIL Risk / Return Rank: 48
PSIL Sharpe Ratio Rank: 46
PSIL Sortino Ratio Rank: 43
PSIL Omega Ratio Rank: 43
PSIL Calmar Ratio Rank: 66
PSIL Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. PSIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	GERM	PSIL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.58	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.42	—

Drawdowns

GERM vs. PSIL - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum PSIL drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for GERM and PSIL.

Drawdown Indicators

	GERM	PSIL	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-92.72%	+92.72%
Max Drawdown (1Y) Largest decline over 1 year	0.00%	-20.38%	+20.38%
Max Drawdown (3Y) Largest decline over 3 years	—	-64.62%	—
Current Drawdown Current decline from peak	0.00%	-76.63%	+76.63%
Average Drawdown Average peak-to-trough decline	0.00%	-76.76%	+76.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	9.63%	-9.63%

Volatility

GERM vs. PSIL - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while AdvisorShares Psychedelics ETF (PSIL) has a volatility of 9.76%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than PSIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GERM	PSIL	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	9.76%	-9.76%
Volatility (6M) Calculated over the trailing 6-month period	0.00%	27.89%	-27.89%
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	41.80%	-41.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	63.15%	-63.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	63.15%	-63.15%

GERM vs. PSIL - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is lower than PSIL's 1.00% expense ratio.

Dividends

GERM vs. PSIL - Dividend Comparison

GERM has not paid dividends to shareholders, while PSIL's dividend yield for the trailing twelve months is around 8.32%.

Position	TTM	2025	2024	2023	2022
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%	0.00%
PSIL AdvisorShares Psychedelics ETF	8.32%	10.95%	1.49%	0.24%	2.91%

Frequently Asked Questions

Which is riskier, GERM or PSIL?

PSIL has higher volatility (9.76%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs PSIL's -92.72%.

Which ETF is better, GERM or PSIL?

On 1-year performance, PSIL leads with 65.52% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GERM or PSIL?

Over the 1-year period, PSIL has performed better with a 65.52% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GERM or PSIL?

GERM is cheaper with a 0.68% expense ratio, compared with 1.00% for PSIL.

Which ETF pays a higher dividend yield, GERM or PSIL?

PSIL has the higher dividend yield at 8.32%, compared with 0.00% for GERM.

What is the main difference between GERM and PSIL?

They also come from different issuers: Amplify and AdvisorShares. Their fees differ too: 0.68% for GERM and 1.00% for PSIL.